Searched for
CARBOGEN AMCIS
Dishman Carbogen Amcis opens $50 million new facility in FranceBuilt on newly acquired land located 7km from an existing CARBOGEN AMCIS site in Riom, the new facility increases product development and m...- Jhunjhunwala's pharma stock bet tanks 19% on poor Q4 numbersThe pharmaceutical player's net loss narrowed to Rs 44.62 crore in the March 2022 quarter. The company reported a net loss of Rs 135.02 cro...
- Jhunjhunwala stock surges 8% as another veteran ups his stakeShares of Dishman Carbogen Amcis jumped 8 per cent up in early trade, after veteran investor Mukul Agrawal upped his stake in the company, ...
- Buy Dishman Carbogen Amcis, target price Rs 230: Yes SecuritiesDishman Carbogen Amcis Ltd., incorporated in the year 2007, is a Small Cap company (having a market cap of Rs 3280.69 Crore) operating in P...
- Dishman Carbogen target price goes up by 100% post I-T raidsNirmal Bang has a ‘Buy’ call on Dishman Carbogen with a target price of Rs 185. Dishman Carbogen Amcis on Thursday said Income Tax Departme...
- I-T searches at Dishman Carbogen Amcis offices, manufacturing units"The officials of Income-Tax Department conducted a search at the Company''s Offices and Manufacturing sites. Company has extended full co-...
- After Market: UB, YES Bank, IFCI surge; 121 stocks hit 52-week lowsBSE benchmark Sensex rose 181 points to 41,461.
- Share market update: GTL Infra, KSS among top losers on BSEMPS Infotecnics, KSS and Dishman Carbogen Amcis were the worst performers.
- Buy Dishman Carbogen Amcis, target Rs 380: HDFC SecuritiesBuy Dishman Carbogen Amcis at a price target of Rs 380.
- Buy Dishman Carbogen Amcis, target Rs 355: HDFC SecuritiesBuy Dishman Carbogen Amcis Ltd. at a price target of Rs 355.
- Buy Dishman Carbogen Amcis, target Rs 415: HDFC SecuritiesBuy Dishman Carbogen Amcis Ltd. at a price target of Rs 415.0 .
- Buy Dishman Carbogen Amcis, target Rs 404: Nirmal Bang Institutional EquitiesBuy Dishman Carbogen Amcis Ltd. at a price target of Rs 404.0 .
- Dishman Pharma zooms 20% as merger with arms becomes effectiveFollowing the announcement, the stock hit its upper circuit limit of 20 per cent at Rs 278.20 on BSE.
- Dishman Pharma shares up over 5% on board's nod for bonusShares of Dishman Pharmaceuticals and Chemicals surged over 5 per cent today after the company's board approved a bonus issue of equity sha...
- Dishman Group appoints Mark Griffiths as CEODrug firm Dishman Pharmaceuticals and Chemicals today said Mark Griffiths has been appointed as Chief Executive Officer of Dishman Group of...
- Dishman acquires Creapharm Parenterals for undisclosed amountDishman Pharma and Chemicals today said its Switzerland-based subsidiary has acquired Creapharm Parenterals for an undisclosed amount.
- Prabhudas puts outperformer on Dishman Pharma; target Rs 449Prabhudas Lilladher has reiterated ‘outperformer’ rating on Dishman Pharmaceuticals for a price target of Rs 449 (15x FY10 earnings), an im...
- Carbogen buyout to help Dishman boost US salesRevenues from the US will see a quantum jump to over 40% of consolidated sales of Dishman Pharmaceuticals & Chemicals this year from around...
- Dishman Pharma buys Swiss co for Rs 349 crHyderabad-based Dishman Pharmaceuticals and Chemicals on Wednesday said it has acquired Swiss research-based company Cabbogen Amcis AG.
- Dishman Pharma acquires Swiss Co for $75 mnDishman Pharmaceuticals and Chemicals Ltd on Wednesday said it has acquired Swiss Research based company Cabbogen Amcis AG from Solutia Eur...
Load More
